Login / Signup

Protocol of the Berlin Long-term Observation of Vascular Events (BeLOVE): a prospective cohort study with deep phenotyping and long-term follow up of cardiovascular high-risk patients.

Joachim E WeberMichael AhmadiLeif-Hendrik BoldtKai Uwe EckardtFrank EdelmannHolger GerhardtUlrike GrittnerKathrin HauboldNorbert HübnerUlf LandmesserDavid Manuel LeistnerKnut MaiDominik N MullerChristian H NolteBurkert PieskeSophie Käthe PiperSimrit RattanGeraldine RauchSein SchmidtKai M Schmidt-OttKatharina SchönrathJeanette Schulz-MengerOliver SchweizerhofBob SiegerinkJoachim SprangerRamachandran S VasanMartin WitzenrathMatthias EndresTobias Pischon
Published in: BMJ open (2023)
First study phase: Approved WHO primary register: German Clinical Trials Register: https://drks.de/search/de/trial/DRKS00016852; WHO International Clinical Registry Platform: http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00016852. Recruitment started on July 18, 2017.Second study phase: Approved WHO primary register: German Clinical Trials Register DRKS00023323, date of registration: November 4, 2020, URL: http://www.drks.de/ DRKS00023323. Recruitment started on January 1, 2021.
Keyphrases
  • clinical trial
  • phase ii
  • phase iii
  • end stage renal disease
  • study protocol
  • chronic kidney disease
  • newly diagnosed
  • open label
  • prognostic factors
  • peritoneal dialysis
  • drug administration
  • double blind